LENZ Therapeutics, Inc Added to NASDAQ Composite Index.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.79 USD | +14.18% | +17.97% | 0.00% |
Apr. 15 | Leerink Partners Starts LENZ Therapeutics With Outperform Rating, $32 Price Target | MT |
Apr. 15 | William Blair Starts LENZ Therapeutics With Outperform Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 454M | |
+18.77% | 125B | |
+14.05% | 108B | |
-7.16% | 23.64B | |
+2.07% | 22.39B | |
-10.79% | 17.78B | |
-41.74% | 16.43B | |
-13.47% | 16.34B | |
+2.23% | 13.56B | |
+27.13% | 11.59B |
- Stock Market
- Equities
- LENZ Stock
- News LENZ Therapeutics, Inc.
- LENZ Therapeutics, Inc.(NasdaqGS: LENZ) added to NASDAQ Composite Index